Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions

被引:43
作者
Chang, Chih-Jung [1 ,2 ,3 ,4 ,5 ,6 ]
Chen, Chun-Bing [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Hung, Shuen-Iu [1 ,2 ,3 ,4 ,7 ]
Ji, Chao [11 ]
Chung, Wen-Hung [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,12 ,13 ]
机构
[1] Chang Gung Mem Hosp, Dept Dermatol, Taipei, Taiwan
[2] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Taipei, Taiwan
[3] Chang Gung Mem Hosp, Dept Dermatol, Keelung, Taiwan
[4] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Keelung, Taiwan
[5] Huaqiao Univ, Xiamen Chang Gung Hosp, Sch Med, Cent Res Lab,Dept Dermatol, Xiamen, Peoples R China
[6] Huaqiao Univ, Xiamen Chang Gung Hosp, Sch Med, Xiamen Chang Gung Allergol Consortium, Xiamen, Peoples R China
[7] Chang Gung Mem Hosp, Dept Med Res, Canc Vaccine & Immune Cell Therapy Core Lab, Taoyuan, Taiwan
[8] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[9] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Keelung, Taiwan
[10] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan
[11] Fujian Med Univ, Affiliated Hosp 1, Dept Dermatol, Fuzhou, Peoples R China
[12] Tsinghua Univ, Beijing Tsinghua Chang Gung Hosp, Sch Clin Med, Dept Dermatol, Beijing, Peoples R China
[13] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
关键词
drug hypersensitivity; pharmacogenetics; severe cutaneous adverse reactions; human-leukocyte antigen; T cell receptor; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; COST-EFFECTIVENESS ANALYSIS; HLA CLASS-I; INDUCED LIVER-INJURY; HLA-B-ASTERISK-1502; ALLELE; T-CELLS; HYPERSENSITIVITY REACTIONS; JAPANESE PATIENTS; ALLOPURINOL HYPERSENSITIVITY;
D O I
10.3389/fphar.2020.00969
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS), are idiosyncratic and unpredictable drug-hypersensitivity reactions with a high-mortality rate ranging from 10% to over 30%, thus causing a major burden on the healthcare system. Recent pharmacogenomic studies have revealed strong associations between SCAR and the genes encoding human-leukocyte antigens (HLAs) or drug-metabolizing enzymes. Some of pharmacogenetic markers have been successfully applied in clinical practice to protect patients from SCAR, such as HLA-B*15:02 and HLA-A*31:01 for new users of carbamazepine, HLA-B*58:01 for allopurinol, and HLA-B*57:01 for abacavir. This article aims to update the current knowledge in the field of pharmacogenomics of drug hypersensitivities or SCAR, and its implementation in the clinical practice.
引用
收藏
页数:11
相关论文
共 108 条
[1]   HLA-B*1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population [J].
Aggarwal, Ritu ;
Sharma, Madhulika ;
Modi, Manish ;
Garg, Vivek Kumar ;
Salaria, Manilla .
HUMAN IMMUNOLOGY, 2014, 75 (11) :1120-1122
[2]   HLA-B locus in Caucasian patients with carbamazepine hypersensitivity [J].
Alfirevic, Ana ;
Jorgensen, Andrea L. ;
Williamson, Paula R. ;
Chadwick, David W. ;
Park, B. Kevin ;
Pirmohamed, Munir .
PHARMACOGENOMICS, 2006, 7 (06) :813-818
[3]   Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex [J].
Bharadwaj, Mandvi ;
Illing, Patricia ;
Theodossis, Alex ;
Purcell, AnthonyW. ;
Rossjohn, Jamie ;
McCluskey, James .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 :401-+
[4]   Stevens-Johnson syndrome associated with abacavir therapy [J].
Bossi, P ;
Roujeau, JC ;
Bricaire, F ;
Caumes, E ;
Caumes, E .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) :902-902
[5]   Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis [J].
Camous, Xavier ;
Calbo, Sebastien ;
Picard, Damien ;
Musette, Philippe .
CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (06) :730-735
[6]  
Cao ZH, 2012, PHARMACOGENOMICS, V13, P1193, DOI [10.2217/PGS.12.89, 10.2217/pgs.12.89]
[7]   Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population [J].
Chang, C-C ;
Ng, C-C ;
Too, C-L ;
Choon, S-E ;
Lees, C-K ;
Chung, W-H ;
Hussein, S. H. ;
Lim, K-S ;
Murad, S. .
PHARMACOGENOMICS JOURNAL, 2017, 17 (02) :170-173
[8]   Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population [J].
Chang, Choong-Chor ;
Too, Chun-Lai ;
Murad, Shahnaz ;
Hussein, Suraiya Hani .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (02) :221-224
[9]   Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians [J].
Chen, Chun-Bing ;
Hsiao, Yi-Hsin ;
Wu, Tony ;
Hsih, Mo-Song ;
Tassaneeyakul, Wichittra ;
Jorns, Teekayu P. ;
Sukasem, Chonlaphat ;
Hsu, Chien-Ning ;
Su, Shih-Chi ;
Chang, Wan-Chun ;
Hui, Rosaline Chung-Yee ;
Chu, Chia-Yu ;
Chen, Yi-Ju ;
Wu, Ching-Ying ;
Hsu, Chao-Kai ;
Chiu, Tsu-Man ;
Sun, Pei-Lun ;
Lee, Hua-En ;
Yang, Chin-Yi ;
Kao, Pei-han ;
Yang, Chih-Hsun ;
Ho, Hsin-Chun ;
Lin, Jing-Yi ;
Chang, Ya-Ching ;
Chen, Ming-Jing ;
Lu, Chun-Wei ;
Ng, Chau Yee ;
Kuo, Kang-Ling ;
Lin, Chien-yio ;
Yang, Ching-Sheng ;
Chen, Ding-Ping ;
Chang, Pi-Yueh ;
Wu, Tsu-Lan ;
Lin, Yu-Jr ;
Weng, Yi-Ching ;
Kuo, Tseng-tong ;
Hung, Shuen-Iu ;
Chung, Wen-Hung .
NEUROLOGY, 2017, 88 (01) :78-86
[10]   Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan [J].
Chen, Pei ;
Lin, Juei-Jueng ;
Lu, Chin-Song ;
Ong, Cheung-Ter ;
Hsieh, Peiyuan F. ;
Yang, Chih-Chao ;
Tai, Chih-Ta ;
Wu, Shey-Lin ;
Lu, Cheng-Hsien ;
Hsu, Yung-Chu ;
Yu, Hsiang-Yu ;
Ro, Long-Sun ;
Lu, Chung-Ta ;
Chu, Chun-Che ;
Tsai, Jing-Jane ;
Su, Yu-Hsiang ;
Lan, Sheng-Hsing ;
Sung, Sheng-Feng ;
Lin, Shu-Yi ;
Chuang, Hui-Ping ;
Huang, Li-Chen ;
Chen, Ying-Ju ;
Tsai, Pei-Joung ;
Liao, Hung-Ting ;
Lin, Yu-Hsuan ;
Chen, Chien-Hsiun ;
Chung, Wen-Hung ;
Hung, Shuen-Iu ;
Wu, Jer-Yuarn ;
Chang, Chi-Feng ;
Chen, Luke ;
Chen, Yuan-Tsong ;
Shen, Chen-Yang .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12) :1126-1133